We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Arbutus Biopharma Corporation | NASDAQ:ABUS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -1.83% | 2.68 | 2.68 | 2.84 | 2.765 | 2.68 | 2.74 | 1,027,603 | 21:00:13 |
British Columbia, Canada | 001-34949 | 98-0597776 | ||||||||||||
(State or other jurisdiction
of incorporation) |
(Commission
File Number) |
(IRS Employer
Identification No.) |
701 Veterans Circle
Warminster, Pennsylvania
|
18974 | |||||||
(Address of principal executive offices) | (Zip Code) |
☐ | Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
☐ | Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
☐ | Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Common Shares, without par value | ABUS | The Nasdaq Stock Market LLC |
Exhibit Number | Description | |||||||
99.1 | ||||||||
104 | Cover page interactive data file (formatted as inline XBRL). |
Arbutus Biopharma Corporation | |||||||||||
Date: August 7, 2020 | By: | /s/ David C. Hastings | |||||||||
Name: | David C. Hastings | ||||||||||
Title: | Chief Financial Officer |
1 Year Arbutus Biopharma Chart |
1 Month Arbutus Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions